Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen
Company announcement – No. 13 / 2023 Zealand Pharma A/S publishes a listing prospectus regarding…
Company announcement – No. 13 / 2023 Zealand Pharma A/S publishes a listing prospectus regarding…
TOKYO, Apr 3, 2023 – (JCN Newswire) – Mitsubishi Heavy Industries, Ltd. (MHI) held a…
HONG KONG, Apr 3, 2023 – (ACN Newswire) – Peijia Medical Limited (“Peijia Medical” or…
DUBLIN–(BUSINESS WIRE)–The “Today’s U.S. Electric Power Industry, Renewable Energy, ISO Markets, and Power Transactions” training…
Paris, France: 03/04/23 – Infinigate, the value-add distributor of cybersecurity, secure networks and secure cloud,…
Rotkreuz, Switzerland: 03/04/23: The Infinigate Group, the value-add distributor of cybersecurity, secure network and secure…
Experienced business executive to help establish the Company as a significant force in the field…
Experienced business executive to help establish the Company as a significant force in the field…
ZURICH, Switzerland, April 03, 2023 (GLOBE NEWSWIRE) — BC Platforms (BCP), a global leader in…
ZURICH, Switzerland, April 03, 2023 (GLOBE NEWSWIRE) — BC Platforms (BCP), a global leader in…
In vivo data demonstrates immune equivalence to traditional needle and syringe injection when using a…
In vivo data demonstrates immune equivalence to traditional needle and syringe injection when using a…
GÉNOMIQUE | THÉRAPIES CELLULAIRES & GÉNÉTIQUES | BIOPRODUCTION Genomic Vision rejoint France BioLead pour participer…
GÉNOMIQUE | THÉRAPIES CELLULAIRES & GÉNÉTIQUES | BIOPRODUCTION Genomic Vision rejoint France BioLead pour participer…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
INSIDE INFORMATION Appointment to drive late-stage clinical development of BioSenic’s cell therapy and autoimmune disease…
INSIDE INFORMATION Appointment to drive late-stage clinical development of BioSenic’s cell therapy and autoimmune disease…
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 3, 2023 – Addex…
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 3, 2023 – Addex…